Pharos Capital Invests in Sanderling Renal Services

May 16, 2022

Pharos Capital Group made a significant growth investment in Sanderling Renal Services to support expansion of the company's home dialysis operations, telemedicine and hospital eDialysis contracts, and geographic growth via acquisitions and de novo clinics. Sanderling, headquartered in Nashville, Tennessee, operates 14 clinics across six states and provides tele-nephrology and acute eDialysis services to 30+ partner hospitals; terms were not disclosed.

Buyers
Pharos Capital Group, LLC
Targets
Sanderling Renal Services, Inc.
Location
Tennessee, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.